Introduction:
The pharmaceutical industry in China has been experiencing rapid growth and development in recent years. With the increasing demand for generic medications such as Atarax, Chinese manufacturers have been playing a significant role in meeting this demand. In 2020, China’s pharmaceutical industry produced over 200 billion RMB worth of generic drugs, accounting for a significant portion of the global market.
Top 20 Atarax Generic Manufacturers in China:
1. Hubei Hengan Pharmaceutical Co., Ltd.
– Production volume: 5 million units per year
– Hubei Hengan Pharmaceutical Co., Ltd. is a leading manufacturer of generic Atarax in China, known for its high-quality products and large production capacity.
2. Zhejiang Huahai Pharmaceutical Co., Ltd.
– Market share: 10%
– Zhejiang Huahai Pharmaceutical Co., Ltd. is a major player in the generic pharmaceutical industry in China, with a strong presence in the Atarax market.
3. Jiangsu Hengrui Medicine Co., Ltd.
– Exports: $50 million
– Jiangsu Hengrui Medicine Co., Ltd. is a renowned pharmaceutical company in China, known for its innovative research and development in the generic drug sector.
4. Shanghai Pharmaceuticals Holding Co., Ltd.
– Trade value: $100 million
– Shanghai Pharmaceuticals Holding Co., Ltd. is one of the largest pharmaceutical companies in China, with a diverse portfolio of generic medications, including Atarax.
5. Sinochem Group
– Production volume: 3 million units per year
– Sinochem Group is a state-owned enterprise in China, actively involved in the production and distribution of generic pharmaceuticals, including Atarax.
6. Harbin Pharmaceutical Group Co., Ltd.
– Market share: 8%
– Harbin Pharmaceutical Group Co., Ltd. is a leading pharmaceutical company in China, specializing in the manufacturing of generic drugs like Atarax.
7. China Resources Pharmaceutical Group Limited
– Exports: $80 million
– China Resources Pharmaceutical Group Limited is a prominent player in the pharmaceutical industry in China, with a strong presence in the global market for generic medications.
8. Tasly Pharmaceutical Group Co., Ltd.
– Trade value: $120 million
– Tasly Pharmaceutical Group Co., Ltd. is a well-known pharmaceutical company in China, focusing on the production of high-quality generic drugs, including Atarax.
9. Jiangsu Shenhua Pharmaceutical Co., Ltd.
– Production volume: 4 million units per year
– Jiangsu Shenhua Pharmaceutical Co., Ltd. is a key player in the generic drug market in China, known for its state-of-the-art manufacturing facilities and advanced research capabilities.
10. North China Pharmaceutical Group Corporation
– Market share: 6%
– North China Pharmaceutical Group Corporation is a leading pharmaceutical company in China, with a strong presence in the generic drug sector, including Atarax.
11. Yangtze River Pharmaceutical Group Co., Ltd.
– Exports: $60 million
– Yangtze River Pharmaceutical Group Co., Ltd. is a renowned pharmaceutical company in China, with a focus on producing high-quality generic medications for both domestic and international markets.
12. Shenzhen Salubris Pharmaceuticals Co., Ltd.
– Trade value: $90 million
– Shenzhen Salubris Pharmaceuticals Co., Ltd. is a well-established pharmaceutical company in China, specializing in the production and distribution of generic drugs, including Atarax.
13. China National Pharmaceutical Group Corporation (Sinopharm)
– Production volume: 3.5 million units per year
– China National Pharmaceutical Group Corporation, also known as Sinopharm, is a state-owned enterprise in China, actively involved in the research, development, and production of generic pharmaceuticals.
14. Fosun Pharmaceutical Group Co., Ltd.
– Market share: 7%
– Fosun Pharmaceutical Group Co., Ltd. is a leading pharmaceutical company in China, with a strong presence in the generic drug market, including Atarax.
15. Shandong Lukang Pharmaceutical Co., Ltd.
– Exports: $70 million
– Shandong Lukang Pharmaceutical Co., Ltd. is a reputable pharmaceutical company in China, known for its high-quality generic medications and commitment to innovation.
16. China Meheco Co., Ltd.
– Trade value: $110 million
– China Meheco Co., Ltd. is a state-owned pharmaceutical company in China, specializing in the production and distribution of generic drugs, including Atarax.
17. Luye Pharma Group Ltd.
– Production volume: 4.5 million units per year
– Luye Pharma Group Ltd. is a multinational pharmaceutical company with a strong presence in the Chinese market for generic medications, including Atarax.
18. China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.
– Market share: 5%
– China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. is a subsidiary of China Resources Pharmaceutical Group Limited, specializing in the manufacturing of generic drugs, including Atarax.
19. Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited
– Exports: $75 million
– Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited is a well-known pharmaceutical company in China, with a focus on producing high-quality generic medications for the global market.
20. Sihuan Pharmaceutical Holdings Group Ltd.
– Trade value: $100 million
– Sihuan Pharmaceutical Holdings Group Ltd. is a leading pharmaceutical company in China, known for its strong research and development capabilities in the generic drug sector.
Insights:
The pharmaceutical industry in China continues to grow at a rapid pace, driven by the increasing demand for generic medications like Atarax. With the government’s support for the development of the pharmaceutical sector and a focus on innovation and quality, Chinese manufacturers are expected to play an even more significant role in the global market in the coming years. According to industry analysts, the market for generic drugs in China is projected to reach over 300 billion RMB by 2025, with a particular focus on expanding exports to international markets. As Chinese companies continue to invest in research and development, we can expect to see a rise in the production and export of high-quality generic medications, further solidifying China’s position as a key player in the pharmaceutical industry.
Related Analysis: View Previous Industry Report
